THERAPY WITH JAK INHIBITORS AND THE RISK OF CARDIOVASCULAR EVENTS IN A DUTCH RHEUMATOID ARTHRITIS POPULATION

被引:0
|
作者
Popa, C. [1 ,2 ]
Opdam, M. [1 ]
Den Broeder, N. [1 ]
Wientjes, M. [1 ]
Den Broeder, A. [1 ,2 ]
机构
[1] Sint Maartensklin, Rheumatol, Ubbergen, Netherlands
[2] Radboudumc, Rheumatol, Nijmegen, Netherlands
关键词
Rheumatoid arthritis; Cardiovascular disease; Targeted synthetic; drugs;
D O I
10.1136/annrheumdis-2023-eular.4033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OP0221
引用
收藏
页码:145 / 146
页数:2
相关论文
共 50 条
  • [21] RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, S. R.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 716 - 716
  • [22] Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Batel-Marques, Francisco
    BMJ OPEN, 2020, 10 (12):
  • [23] Prevalence of traditional and novel cardiovascular risk factors and cardiovascular events in rheumatoid arthritis in a large population study.
    de Pablo, P
    Dietrich, T
    Karlson, EW
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S706 - S707
  • [24] Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis
    Nossent, H
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (09) : 2282 - +
  • [25] CUMULATIVE DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS AND THE RISK OF CARDIOVASCULAR EVENTS
    Solomon, D. H.
    Reed, G. W.
    Kremer, J. M.
    Curtis, J.
    Farkouh, M.
    Harrold, L. P.
    Hochberg, M.
    Tsao, P.
    Greenberg, J. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 637 - 638
  • [26] Weight Fluctuation and the Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis
    Baker, Joshua F.
    Reed, George
    Kremer, Joel
    ARTHRITIS CARE & RESEARCH, 2022, 74 (02) : 229 - 235
  • [27] Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
    Mal, Kheraj
    Kumar, Ratan
    Mansoor, Farah
    Kaur, Navneet
    Kumar, Anil
    Memon, Sidra
    Rizwan, Amber
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [28] Weight Fluctuation and Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis
    Baker, Joshua
    Reed, George
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [29] EFFICACY OF JAK INHIBITORS IN REFRACTORY RHEUMATOID ARTHRITIS
    Kamiya, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1468 - 1468
  • [30] JAK INHIBITORS: A BROADENING APPROACH IN RHEUMATOID ARTHRITIS
    Lam, S.
    DRUGS OF TODAY, 2016, 52 (08) : 467 - 469